We have seen inflows into the biotech sector, says Mara Goldstein, Managing Director & Sr. Biotechnology Analyst, Mizuho Americas. They are looking at cash runway and available capital for R&D in the companies. She discusses oncology companies including Arcus (RCUS) with their large amount of cash. She delves into the specifics of several other companies including Xencor (XNCR). Tune in for the specifics.
28 Mar 2022
Morning Trade Live
23 Mar 2022
Trading 360
09 Mar 2022
Morning Trade Live
18 Mar 2022
Morning Trade Live
23 Mar 2022
The Watch List
20 May 2022
The Watch List
02 May 2022